This oil-based carrier provides enhanced penetration for lipophilic compounds while simultaneously delivering moisturizing benefits
Another brand of Semaglutide is Wegovy, which is specifically marketed for weight loss
However, to date, extensive RCTs have shown no correlation between specific GLP-1 RAs and increased cancer risk
However, as their use expands, potential interaction risks are drawing increased attention
Guidance from the Centers for Disease Control (CDC) published in 2024 also supports the correlation between weight loss and lowering risk for T2D
However, these treatments may indirectly affect B12 levels through slowed gastric emptying, reduced dietary intake due to appetite suppression, and interaction with concurrent metformin use, which is known to reduce B12 absorption